GO:0042355 L-fucose catabolic process: Metabolic Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042355 L-fucose catabolic process describes the biochemical breakdown of L-fucose (6-deoxy-L-galactose), a monosaccharide that also serves as a key substrate for protein fucosylation.
• L-fucose catabolism intersects with salvage and de novo GDP-L-fucose synthesis pathways, influencing cellular fucosylation capacity.
• The process is relevant to cancer biology, immunity, and metabolic disorders, as L-fucose availability modulates antitumor immunity and inflammation.
• Key enzymes include L-fucose kinase (fucokinase, FUK), L-fucose-1-phosphate aldolase (FucA), and L-fucose dehydrogenase (FucDH), which convert L-fucose to dihydroxyacetone phosphate and L-lactaldehyde.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise interrogation of L-fucose catabolic genes in disease contexts.
• Understanding L-fucose catabolism supports metabolic engineering for L-fucose production and therapeutic targeting of fucosylation-dependent pathways.
Description
L-fucose catabolic process (GO:0042355) is defined as the chemical reactions and pathways resulting in the breakdown of L-fucose (6-deoxy-L-galactose). L-fucose is a unique monosaccharide that is either salvaged from extracellular sources or synthesized de novo, and its catabolism provides a route to recycle this sugar into central metabolic intermediates. The process is tightly linked to the availability of GDP-L-fucose, the donor substrate for fucosylation, and thus impacts a wide range of biological functions including cell signaling, immune recognition, and host-microbe interactions. Researchers study L-fucose catabolism to understand how metabolic flux through this pathway influences fucosylation-dependent processes in health and disease. The pathway is also of biotechnological interest for the production of L-fucose and fucosylated oligosaccharides. This article integrates authoritative QuickGO annotation and verified PubMed literature to provide a comprehensive overview of the genes, mechanisms, and research models relevant to GO:0042355.
L-fucose catabolic process At A Glance
| GO ID | GO:0042355 |
|---|---|
| GO term | L-fucose catabolic process |
| Ontology | biological_process |
| Synonym | L-fucose breakdown, L-fucose catabolism, L-fucose degradation |
| Major function | Breakdown of L-fucose to dihydroxyacetone phosphate and L-lactaldehyde, linking to glycolysis and detoxification pathways |
| Related pathways | Fucosylation, GDP-L-fucose salvage, glycan metabolism |
| Key enzymes | Fucokinase (FUK), L-fucose-1-phosphate aldolase (FucA), L-fucose dehydrogenase (FucDH) |
| Cellular location | Cytoplasm (soluble enzymes) |
| Research relevance | Cancer, immunity, metabolic engineering, inflammation |
What Is GO:0042355?
GO:0042355 L-fucose catabolic process encompasses the enzymatic steps that convert L-fucose into simpler metabolites, ultimately yielding intermediates that can enter central carbon metabolism. The term is a child of monosaccharide catabolic process and includes both the salvage of L-fucose from glycoconjugates and its direct degradation. The pathway is distinct from L-fucose biosynthesis and is often studied in the context of fucosylation regulation and metabolic disorders.
Why Is L-fucose catabolic process Important in Cell Biology?
L-fucose catabolic process is critical because it regulates the intracellular pool of L-fucose, which directly affects GDP-L-fucose levels and protein fucosylation. Fucosylation is essential for many biological processes, including immune cell trafficking, receptor signaling, and cancer progression. Dysregulation of L-fucose catabolism has been implicated in metabolic disorders, inflammation, and tumorigenesis, making it a potential therapeutic target. Moreover, understanding this pathway enables metabolic engineering for L-fucose production and the design of fucosylated biologics.
• Regulates GDP-L-fucose availability for protein O-fucosylation and N-fucosylation.
• Modulates antitumor immunity and immunotherapy responses.
• Influences inflammation and pyroptosis in obesity-related cardiac injury.
• Provides metabolic intermediates for central carbon metabolism.
• Enables biotechnological production of L-fucose.
• Impacts colorectal cancer cell fucosylation and serine metabolism.
• Links to GLUT1-mediated L-fucose transport and cellular uptake.
• Involved in plant GDP-L-fucose transport and cell wall polysaccharide synthesis.
What Happens During L-fucose catabolic process?
Uptake and Salvage of L-fucose
In simple terms: Cells take up L-fucose from the environment or recycle it from degraded glycans.
L-fucose can be transported into cells via GLUT1, which acts as a highly efficient L-fucose transporter. Once inside, L-fucose can be salvaged from fucosylated glycoconjugates or directly catabolized. The salvage pathway converts free L-fucose to GDP-L-fucose through the action of fucokinase and GDP-fucose pyrophosphorylase, but when L-fucose is in excess, catabolic enzymes divert it to degradation.
Phosphorylation by Fucokinase
In simple terms: The first step of breakdown adds a phosphate group to L-fucose.
Fucokinase (FUK) phosphorylates L-fucose to L-fucose-1-phosphate, consuming ATP. This step traps the sugar inside the cell and commits it to either salvage or catabolism. In engineered Escherichia coli, overexpression of fucokinase and other pathway genes enhances L-fucose production, indicating the reversibility and importance of this step.
Cleavage by L-fucose-1-phosphate aldolase
In simple terms: The phosphorylated sugar is split into two smaller molecules.
L-fucose-1-phosphate aldolase (FucA) cleaves L-fucose-1-phosphate into dihydroxyacetone phosphate (DHAP) and L-lactaldehyde. DHAP enters glycolysis, while L-lactaldehyde is further metabolized to L-lactate or pyruvate. This aldolase step is a key catabolic branch point that determines the fate of L-fucose carbon.
Oxidation by L-fucose dehydrogenase
In simple terms: An alternative route oxidizes L-fucose directly.
L-fucose dehydrogenase (FucDH) oxidizes L-fucose to L-fuconolactone, which is subsequently hydrolyzed to L-fuconate. This pathway is present in some bacteria and fungi and contributes to L-fucose utilization as a carbon source. The enzyme provides a bypass to the phosphorylative route and is studied for biotechnological applications.
Integration into Central Metabolism
In simple terms: The breakdown products feed into energy-producing pathways.
The end products of L-fucose catabolism, DHAP and L-lactaldehyde (or pyruvate), enter glycolysis and gluconeogenesis, supporting energy production and biosynthesis. This integration links L-fucose catabolism to cellular metabolic status and influences fucosylation capacity by altering substrate availability.
Key Genes Involved in GO:0042355 L-fucose catabolic process
The following genes and enzymes are directly implicated in L-fucose catabolic process and its regulation, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FUK | Fucokinase; phosphorylates L-fucose to L-fucose-1-phosphate | Key enzyme in salvage and catabolism; target for metabolic engineering |
| FucA | L-fucose-1-phosphate aldolase; cleaves L-fucose-1-phosphate to DHAP and L-lactaldehyde | Central catabolic enzyme; studied in bacteria and eukaryotes |
| FucDH | L-fucose dehydrogenase; oxidizes L-fucose to L-fuconolactone | Alternative catabolic route; biotechnological potential |
| FUCA1 | Alpha-L-fucosidase; hydrolyzes fucosylated glycans to release L-fucose | Lysosomal enzyme; defects cause fucosidosis |
| FUCA2 | Alpha-L-fucosidase; plasma enzyme involved in fucose salvage | Potential biomarker; role in cancer |
| GMDS | GDP-mannose 4,6-dehydratase; de novo GDP-L-fucose synthesis | Links de novo synthesis to catabolism |
| TSTA3 | GDP-L-fucose synthase; converts GDP-4-keto-6-deoxymannose to GDP-L-fucose | Regulates fucosylation capacity |
| SLC2A1 (GLUT1) | Facilitates L-fucose transport | Highly efficient L-fucose transporter; affects cellular uptake |
| FUT8 | Alpha-1,6-fucosyltransferase; adds fucose to N-glycans | Competes with catabolism for L-fucose |
| POFUT1 | Protein O-fucosyltransferase 1; adds fucose to EGF repeats | O-fucosylation; affected by L-fucose levels |
| POFUT2 | Protein O-fucosyltransferase 2; adds fucose to TSR domains | O-fucosylation; linked to Notch signaling |
| GFUS | GDP-L-fucose synthase (same as TSTA3) | Salvage pathway enzyme |
| FCSK | Fucokinase (same as FUK) | Phosphorylates L-fucose in salvage |
| FPGT | GDP-L-fucose pyrophosphorylase; converts L-fucose-1-phosphate to GDP-L-fucose | Salvage pathway |
| SLC35C1 | GDP-fucose transporter; transports GDP-fucose into Golgi | Defects cause leukocyte adhesion deficiency II |
| SLC35C2 | GDP-fucose transporter paralog | Modulates fucosylation |
| TLR4 | Toll-like receptor 4; mediates L-fucose effects on inflammation | L-fucose alleviates cardiac injury via TLR4/MyD88/NF-κB |
| MYD88 | Adaptor protein in TLR signaling | Involved in L-fucose-mediated anti-inflammatory effects |
How Is L-fucose catabolic process Regulated?
L-fucose catabolic process is regulated at multiple levels. Substrate availability is controlled by GLUT1-mediated transport and by alpha-L-fucosidases that release fucose from glycoconjugates. Enzyme expression is modulated by metabolic demand; for example, fucokinase and aldolase levels change in response to L-fucose availability. In cancer cells, L-fucose promotes fucosylation by increasing serine accumulation, indirectly affecting catabolic flux. Inflammatory signaling through TLR4/MyD88/NF-κB can be modulated by L-fucose, suggesting feedback between catabolism and immune pathways. Additionally, GDP-L-fucose transport in plants and mammals influences the balance between salvage and catabolism.
L-fucose catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FUCA1 | Fucosidosis (lysosomal storage disease) | FUCA1 knockout cell lines; enzyme replacement studies |
| SLC35C1 | Leukocyte adhesion deficiency II | SLC35C1 knockout iPSCs; neutrophil adhesion assays |
| FUT8 | Cancer progression, immune evasion | FUT8 knockout cancer cells; xenograft models |
| TLR4 | Obesity-related cardiac injury, inflammation | TLR4 knockout mice; cardiomyocyte models |
| GMDS | Metabolic disorders, fucosylation defects | GMDS knockout cell lines; metabolomics |
L-fucose catabolism in cancer
Altered L-fucose metabolism is observed in colorectal cancer, where L-fucose increases fucosylation of cancer cells via promoting serine accumulation, supporting tumor growth and immune evasion. L-fucose also regulates antitumor immunity and immunotherapy responses, making catabolic enzymes potential targets. The expression of fucosidases and fucosyltransferases is often dysregulated in tumors, affecting cell adhesion and signaling.
Inflammation and cardiac injury
L-fucose alleviates inflammation, pyroptosis, and mitochondrial injury in obesity-related cardiac injury via the TLR4/MyD88/NF-κB pathway. This suggests that L-fucose catabolism may modulate inflammatory signaling, and its dysregulation could contribute to cardiovascular complications.
Leukocyte adhesion deficiency and fucosylation disorders
Defects in GDP-fucose transport (SLC35C1) cause leukocyte adhesion deficiency type II, characterized by impaired fucosylation and immune defects. L-fucose catabolism intersects with this pathway by regulating the pool of L-fucose available for GDP-fucose synthesis.
Metabolic engineering and biotechnology
Engineered Escherichia coli strains with optimized L-fucose catabolic and salvage genes are used for L-fucose production. Understanding catabolic flux is essential for balancing yield and degradation in industrial bioprocesses.
From L-fucose catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FUK loss affect L-fucose catabolism and fucosylation? | FUK knockout cell lines (CRISPR-Cas9) |
| What is the catalytic role of FucA in L-fucose breakdown? | FucA point-mutation knock-in cells |
| How does L-fucose uptake affect catabolic flux? | GLUT1 (SLC2A1) overexpression or knockout cells |
| Can L-fucose catabolism be redirected for production? | Engineered E. coli with knock-in of fucokinase and aldolase |
| Does L-fucose modulate inflammation via TLR4? | TLR4 knockout macrophages treated with L-fucose |
| What is the impact of fucosylation on cancer? | FUT8 knockout or overexpression in colorectal cancer cells |
How to Study the L-fucose catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | L-fucose and intermediates | Quantify catabolic flux |
| 13C flux analysis | Carbon flow through pathway | Metabolic engineering |
| Enzyme activity assays | Fucokinase, aldolase, dehydrogenase activity | Kinetic characterization |
| CRISPR knockout screens | Gene essentiality for L-fucose utilization | Identify novel catabolic genes |
| Lectin blotting | Protein fucosylation levels | Assess impact on fucosylation |
| Glycan mass spectrometry | Fucosylated glycan structures | Structural analysis |
| qRT-PCR | mRNA expression of catabolic genes | Regulation studies |
| Western blot | Protein levels of enzymes | Validate knockout/overexpression |
Metabolomics and flux analysis
Liquid chromatography-mass spectrometry (LC-MS) and nuclear magnetic resonance (NMR) can quantify L-fucose and its catabolic intermediates (L-fucose-1-phosphate, DHAP, L-lactaldehyde) to assess pathway activity. Isotope tracing with 13C-labeled L-fucose enables flux analysis through catabolic and salvage branches.
Enzymatic assays
Fucokinase, aldolase, and dehydrogenase activities can be measured spectrophotometrically using coupled enzyme assays. These methods are used to characterize enzyme kinetics and inhibitor effects.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes required for L-fucose catabolism and fucosylation. Libraries targeting metabolic enzymes reveal synthetic lethal interactions.
Glycan analysis and fucosylation profiling
Lectin blotting, mass spectrometry of glycans, and flow cytometry with fucose-specific lectins (e.g., UEA-I) measure changes in protein fucosylation upon modulation of L-fucose catabolism.
How CRISPR Can Be Used to Study GO:0042355 L-fucose catabolic process
Knockout
CRISPR-Cas9 knockout of FUK, FucA, or FucDH in cell lines abolishes specific steps of L-fucose catabolism, allowing researchers to assess the contribution of each enzyme to fucosylation and cellular metabolism. Knockout of FUCA1 or SLC35C1 models lysosomal storage and leukocyte adhesion defects.
Point Mutation
Point mutations in catalytic residues of FucA or FUK can be introduced via CRISPR base editing or homology-directed repair to dissect enzyme mechanism without complete loss of protein. Such models help distinguish catalytic activity from scaffolding functions.
Knock-in
Knock-in of tagged versions of catabolic enzymes (e.g., GFP-FucA) enables live-cell imaging and proteomic analysis. Knock-in of disease-associated mutations in FUCA1 or SLC35C1 recapitulates patient phenotypes.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of FUK, FucA, or FucDH increases catabolic flux, reducing intracellular L-fucose and altering fucosylation patterns. This is useful for metabolic engineering and studying pathway saturation.
How EDITGENE Supports L-fucose catabolic process Research
Researchers studying L-fucose catabolic process-related genes often need to determine whether a candidate gene is causally involved in L-fucose breakdown, fucosylation, or disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for L-fucose catabolic process research.
Frequently Asked Questions About L-fucose catabolic process
What is GO:0042355 L-fucose catabolic process?
GO:0042355 is a Gene Ontology biological process term describing the chemical reactions and pathways that break down L-fucose (6-deoxy-L-galactose) into simpler metabolites.
What genes are involved in L-fucose catabolic process?
Key genes include FUK (fucokinase), FucA (L-fucose-1-phosphate aldolase), FucDH (L-fucose dehydrogenase), and FUCA1 (alpha-L-fucosidase).
How is L-fucose catabolism related to fucosylation?
L-fucose catabolism regulates the intracellular pool of L-fucose, which is a substrate for GDP-L-fucose synthesis and protein fucosylation.
What diseases are associated with L-fucose catabolic process?
Defects in fucosylation and L-fucose metabolism are linked to leukocyte adhesion deficiency II, fucosidosis, cancer, and inflammatory conditions.
How do researchers study L-fucose catabolic process?
Methods include metabolomics, enzyme assays, CRISPR knockout screens, and glycan profiling.
What is the role of GLUT1 in L-fucose catabolism?
GLUT1 (SLC2A1) is a highly efficient L-fucose transporter that facilitates cellular uptake of L-fucose for catabolism or salvage.
Can L-fucose catabolism be targeted for cancer therapy?
L-fucose metabolism influences antitumor immunity and immunotherapy responses, suggesting that targeting catabolic enzymes may enhance treatment efficacy.
What are the end products of L-fucose catabolism?
L-fucose is broken down to dihydroxyacetone phosphate (DHAP) and L-lactaldehyde, which enter central metabolism.
How does L-fucose affect inflammation?
L-fucose alleviates inflammation and pyroptosis via the TLR4/MyD88/NF-κB pathway in obesity-related cardiac injury.
What CRISPR models are available for L-fucose catabolic genes?
EDITGENE offers knockout, point mutation, knock-in, and overexpression models for FUK, FucA, FucDH, and related genes.
Conclusion
L-fucose catabolic process (GO:0042355) is a fundamental metabolic pathway that controls L-fucose availability for fucosylation and energy production. Its dysregulation is implicated in cancer, inflammation, and inherited disorders, making it a compelling target for therapeutic and biotechnological applications. Advances in CRISPR-based models and metabolomics continue to unravel the mechanistic details of this pathway, offering new opportunities for intervention. EDITGENE provides the tools to accelerate this research through precise genome editing and screening services.
References
- 1. Gong J et al.. 2025. L-Fucose alleviates inflammation, pyroptosis and mitochondrial injury in obesity-related cardiac injury via TLR4/MyD88/NF-κB pathway.. J Transl Med 23(1):1385 PMID: 41361467
- 2. Liu JJ et al.. 2019. L-Fucose production by engineered Escherichia coli.. Biotechnol Bioeng 116(4):904-911 PMID: 30597526
- 3. Ng BG et al.. 2023. GLUT1 is a highly efficient L-fucose transporter.. J Biol Chem 299(1):102738 PMID: 36423686
- 4. Holdener BC et al.. 2019. Protein O-fucosylation: structure and function.. Curr Opin Struct Biol 56:78-86 PMID: 30690220
- 5. Adhikari E et al.. 2022. L-fucose, a sugary regulator of antitumor immunity and immunotherapies.. Mol Carcinog 61(5):439-453 PMID: 35107186
- 6. Ebert B et al.. 2017. GDP-L-fucose transport in plants: The missing piece.. Channels (Austin) 11(1):8-10 PMID: 27588459
- 7. Wang Y et al.. 2024. Research progress on the functions, preparation and detection methods of l-fucose.. Food Chem 433:137393 PMID: 37672945
- 8. Yao Y et al.. 2023. L-Fucose increases the fucosylation of colorectal cancer cells via promoting the accumulation of serine.. Food Funct 14(9):4314-4326 PMID: 37078695
